Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$560,653
+$200,708 QoQ
Shares Held
2,228
+34.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#3,058
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOCUSED ALPHA, LLC holds $7,039,189 across 11 Drug Manufacturers - General names. ABBV ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
3,561 | $1,289,509 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
9,034 | $1,141,355 | |
| 3 | JNJ |
Johnson & Johnson
|
3,326 | $844,704 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,009 | $772,156 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,253 | $590,777 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
2,228 | $560,653 | |
| 7 | PFE |
Pfizer Inc
|
21,223 | $511,049 | |
| 8 | LLY |
ELI LILLY & Co
|
406 | $486,968 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $560,653 | 2,228 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $359,945 | 1,655 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $398,715 | 1,745 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||